Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VYOCURE AB
AB
Active
Org 5593717126
Linjegatan 3 D, 302 50
Halmstad
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2022 · 4 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
VYOCURE AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
-1M
-100%
2023
-1M
0%
2024
-1M
0%
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
0
0
0
0
Staff expenses
−0
−0
−7
−1
EBITDA
−284
−1 365
−668
−1 233
Depreciation & amort.
−5
−59
−59
−59
EBIT
−289
−1 423
−726
−1 291
Net financials
0
0
−60
−121
Profit before tax
−289
−1 423
−786
−1 412
Tax
—
—
—
—
Net profit
−289
−1 423
−786
−1 412
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
359
343
3 374
2 279
Equity
36
342
1 188
181
Long-term debt
282
0
1 010
1 952
Short-term debt
41
1
1 068
43
Total debt
323
1
2 078
1 995
Financial ratios
5-year trend
EBITDA margin
-123266600.0%
This company
15.8%
Market median
-780168454% vs market
2022
2025
Equity ratio
8.0%
This company
38.2%
Market median
-79% vs market
2022
2025
Return on equity
-778.8%
This company
18.4%
Market median
-4333% vs market
2022
2025
Net profit margin
-141176400.0%
This company
8.1%
Market median
-1742918619% vs market
2022
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2022
2025
Debt / equity
11.57×
This company
0.62×
Market median
-1766% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-03-22 – 2022-12-31
View
PDF
More on VYOCURE AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
